Abiopharma

Clene to Present at the Emerging Growth Conference

(99% Neutral) HANMI FINANCIAL CORP (HAFC) Announces Business Combination

Director BALBIRNIE BRIAN R 🟢 acquired 10.0K shares of ACCESS Newswire Inc. (ACCS) at $4.95 Transaction Date: Aug 14, 2026 | Filing ID: 006517

Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Director Bond Ryan 🟢 acquired 21.1K shares of Aclarion, Inc. (ACON) at $2.37 Transaction Date: Aug 13, 2026 | Filing ID: 006516

Director Pollard Wesley T 🟢 acquired 2.0K shares of ACCESS Newswire Inc. (ACCS) at $4.99 Transaction Date: Aug 14, 2026 | Filing ID: 006515

(10% Negative) FULCRUM THERAPEUTICS, INC. (FULC) Announces Business Combination

Director Wesemann William 🟢 acquired 2.1K shares of Aclarion, Inc. (ACON) at $2.34 Transaction Date: Aug 13, 2026 | Filing ID: 006514

Director Neal David K 🟢 acquired 7.5K shares of Aclarion, Inc. (ACON) at $2.40 Transaction Date: Aug 13, 2026 | Filing ID: 006513

Director Ness Brent 🟢 acquired 5.2K shares of Aclarion, Inc. (ACON) at $2.31 Transaction Date: Aug 13, 2026 | Filing ID: 006512

FingerMotion Completes Acquisition of 9.9% Interest in Lyken AI Computing

Investview, Inc. Reports Second-Quarter 2026 Financial Results and Strategic Business Update

Duos Technologies Signs Five-Year, 55 MW Hosting Agreements with Axe Compute Valued at Over $500 Million

CEL-SCI Reports Fiscal Third Quarter 2026 Results

Beyond Oil Successfully Completes Industrial-Scale Validation of Patented Chemistry, Demonstrating Substantial Reductions in Harmful Frying-Oil Degradation Compounds